Compare KDK & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KDK | KOD |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | N/A | 2018 |
| Metric | KDK | KOD |
|---|---|---|
| Price | $8.61 | $25.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $15.63 | ★ $28.29 |
| AVG Volume (30 Days) | 354.7K | ★ 656.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.60 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $253.02 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.43 | $1.92 |
| 52 Week High | $11.35 | $31.18 |
| Indicator | KDK | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 53.93 |
| Support Level | $8.28 | $21.51 |
| Resistance Level | $9.45 | $27.99 |
| Average True Range (ATR) | 0.39 | 2.02 |
| MACD | -0.03 | 0.33 |
| Stochastic Oscillator | 33.33 | 66.67 |
Kodiak AI Inc is engaged in the commercial trucking industry and the public sector, based on AI-powered autonomous vehicle technology.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.